Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.

News

Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Important Notice: Investments in unquoted companies carries high risks and investors could lose all funds invested. Investors should not invest if capital is required in the near term. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Past performance is not a guide to the future performance of an investment, and investors are encouraged to take independent legal, tax and financial advice before considering an investment.
EIS Product Overview Brochures

Deepbridge would like to introduce our new EIS Product Overview Brochures; giving you a chance to look at both our EIS propositions, The Deepbridge…

Full article
SEIS Product Overview Brochures

Deepbridge would like to introduce our new SEIS Product Overview Brochures; giving you a chance to look at both our SEIS propositions, The Deepbridge…

Full article
EIS Documents

  In August, HM Treasury confirmed the Commencement regulations for the Finance Act 2018, which make changes to the Enterprise Investment…

Full article
SEIS Documents

  Deepbridge Innovation SEIS and Deepbridge Life Sciences SEIS have therefore been updated accordingly. Please find links to documentation…

Full article
Ian Warwick shortlisted for Award

Ian Warwick has been shortlisted for 'Dealmaker of the Year' at the upcoming North West Business Insider Dealmaker Awards. Taking place at…

Full article
Deepbridge invest £150k into Mynurva

Deepbridge have recently deployed an investment of £150,000 into Mynurva Limited, through the Deepbridge Life Sciences SEIS portfolio.   About…

Full article
Deepbridge invests £250k into Levitex Foams

  Deepbridge has recently deployed an investment of £250,000 into Levitex Foams Limited, through the Deepbridge Life Sciences EIS fund. This…

Full article
Almac and Elasmogen receive £2m grant

The biopharmaceutical company Almac Discovery - part of the contract development and manufacturing organisation (CDMO) Almac Group -and Elasmogen, a…

Full article
Glyconics sign hardware partner agreement

  Deepbridge are pleased to report that Glyconics, which is part of the Deepbridge Life Sciences SEIS portfolio, have signed a hardware partner…

Full article
Women in Financial Advice Awards 2018

      “I am delighted to report that Louise Farley, Deepbridge Partner and Head of Business Development, has been shortlisted for…

Full article
Deepbridge nominated for 4 awards

  Deepbridge are delighted to announce that we have been nominated for 4 awards at the upcoming Growth Investor Awards 2018, taking place in…

Full article
Deepbridge case studies available

  We now have the following Deepbridge case studies available:   Enterprise Investment Scheme Case Studies Income Tax Capital Gains…

Full article